Home
Kadmon

Kadmon Market Share Analysis for April 2026

Health > Biotechnology and Pharmaceuticals

Domainkadmon.com

Year Founded2009

Employees51 - 200

Annual Revenue$5M - $10M

Kadmon

Kadmon (including company regionals)

kadmon.com

See more website traffic and engagement information

Kadmon Revenue up to April 2026 is 5M - 10M

revenue generated by Kadmon top domains

Kadmon top domains revenue over 3 years

Revenue for Kadmon top domains

kadmon.com5M - 10M

See more with Sales Intelligence

Total visits to Kadmon's top domains

Understand Kadmon market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Kadmon's top domains

Analyze Kadmon engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Kadmon's top domains

See how Kadmon keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Kadmon top competitors by domain

Top similar sites in April 2026, ranked by their affinity

west-ward.comCompany NameWest-Ward PharmaceuticalsEmployees501 - 1000HQUnited Kingdom, LondonAnnual revenue$10M - $15MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Kadmon

These are the website technologies, by industry, used by Kadmon top domains

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

Advertising (1)

PubMatic

Business Solutions (1)

DocuSign

More Technologies

6

See all

News & Signals from Kadmon

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSanofi partners with Kadmon Holdings, Inc..Sanofi announced that it has entered into an agreement to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company leveraging its proprietary, clinically validated XTEN® and innovative universal protease-releasable masking technology platform, Pro-XTENTM, to discover and develop tra ... more Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease areas of significant unmet medical needs.

NewsCarver left Kadmon Holdings, Inc. as chief accounting officer on Feb 22nd '22.Mr. Carver joins Evommune from Kadmon Holdings, Inc., a Sanofi Company, where he served in various roles, most recently as chief accounting officer.

NewsKadmon Holdings, Inc. partnered with Party Animalz Entertainment Llc on Jul 28th '21.Meanwhile, Kadmon had entered a confidentiality agreement with standstill provisions with Party A, which during a meeting at its European headquarters on July 28, indicated that it was also interested in acquiring the New York biotech.